Placebo-Controlled Study
A clinical trial where the control group receives an inactive substance identical in appearance to the active treatment. Placebo controls distinguish the true drug effect from the placebo effect and natural disease progression. For injectable peptide trials, placebos use matching injection devices.
Technical Context
Placebo-controlled designs require ethical justification — they are appropriate when no proven effective treatment exists for the condition, when withholding treatment poses no serious risk, or when adding the new drug to standard of care (placebo + SoC vs drug + SoC). For GLP-1 RA diabetes trials, placebo controls are justified as add-on to existing therapy (metformin, sulfonylureas, or insulin). The placebo response in weight management trials (typically 2-4% weight loss from lifestyle intervention alone) provides important context for interpreting drug effects. Nocebo effects (negative expectations causing adverse events in the placebo group) also occur — in GLP-1 RA trials, nausea rates of 4-10% in placebo groups illustrate this phenomenon.